Acella Pharmaceuticals is recalling 482,533 bottles of NP Thyroid (thyroid tablets, USP) because routine testing found some lots to be subpotent, meaning they contain less than 90% of the labeled amount of Liothyronine (T3). The recall affects multiple strengths of the medication, including 15 mg, 30 mg, 60 mg, 90 mg, and 120 mg tablets sold in 7-count and 100-count bottles. These prescription medications were distributed nationwide across the United States and Puerto Rico.
Patients who take subpotent thyroid medication may experience symptoms of hypothyroidism, such as fatigue, weight gain, hair loss, and depression. This risk is especially critical for pregnant women or infants, as low thyroid levels can negatively impact fetal development or growth.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Image 2 - Labeling, NP Thyroid 15

Labeling, NP Thyroid 30

Labeling, NP Thyroid 60

Labeling, NP Thyroid 90

Labeling, NP Thyroid 120

Labeling, NP Thyroid 15, professional sample

Labeling, NP Thyroid 30, professional sample

Labeling, NP Thyroid 120, professional sample

Photo, NP Thyroid 15mg

Photo, NP Thyroid 30 mg

Photo, NP Thyroid 60 mg

Photo, NP Thyroid 90 mg

Photo, NP Thyroid 120 mg
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.